“Count Me In” Campaign Launches, Sharing Real Stories to Highlight Support for COVID-19 Vaccination

March 11, 2021

(Washington, D.C., Thursday, March 11, 2021) – The COVID-19 Vaccine Education and Equity Project, a group of more than 160 leading organizations representing patient, provider, employer and public health organizations launched “Count Me In,” a campaign to provide individuals and organizations with information to build confidence in authorized COVID-19 vaccines, and to motivate and inspire people to collectively fight the pandemic.

“Count Me In” provides individuals and organizations with tools to express their commitment to COVID-19 vaccination as communities across the country strive to reopen and return to normal. The campaign also encourages adults to share their stories about why they were vaccinated or why they are encouraged to be vaccinated against COVID-19, once vaccines are available to them.

Convened by the Alliance for Aging ResearchHealthyWomen, and the National Caucus and Center on Black Aging, Inc., the COVID-19 Vaccine Education and Equity Project has more than doubled its membership of organizations representing patients, caregivers and families, diverse communities, health care workers, older Americans, veterans, frontline workers and scientists since its December 2020 launch. One of the project’s objectives has been to convene a dialogue among organizations representing the multitude of constituencies that face challenges from COVID-19, particularly diverse populations that have been most harmed, and those on the front lines of the pandemic. 

The project works collaboratively to provide information about the clinical trials process, regulatory review, distribution of and access to COVID-19 vaccines in a way that promotes equity and trust. This work is guided by a core belief that approval and dissemination of COVID-19 vaccines must be based on:

  • Robust clinical trials that include diverse patient populations;
  • Public disclosure of results from Phase 3 clinical trials, in accordance with FDA guidance;
  • Authorization and subsequent approval based on evidence generated from clinical trials and well-established review processes at FDA; and
  • Transparent and ongoing post-marketing safety surveillance.

About the COVID-19 Vaccine Education and Equity Project:

As more than 150 leading organizations representing patients, caregivers and families, diverse communities, healthcare workers, older Americans, veterans, frontline workers and scientists, the COVID-19 Vaccine Education and Equity Project launched in December 2020 to provide information about the clinical trials process, regulatory review, distribution of and access to COVID-19 vaccines in a way that promotes equity and trust. Initial support for the project has been provided by Pfizer, Inc.

Comments are closed.